After the U.S. Preventive Services Task Force (USPSTF) updated its biennial mammography screening recommendations to begin at 40 years of age, women in their 40s accounted for approximately 50 percent of all screening mammography exams, according to new study findings to be presented at the American Society of Clinical Oncology (ASCO) conference.
The combination of sustained high-gradient performance and AI capabilities with the Titanion MR may facilitate the use of imaging biomarkers that provide insight into tissue microstructure
In a recent interview with Diagnostic Imaging, Leslie Lamb, MD, MSc, discussed findings from new mammography research that showed an 89.3 percent sensitivity for detecting invasive lobular carcinoma (ILC) with adjunctive AI.
Emerging MRI findings from phase 3 research revealed that over 28 percent of patients with perianal fistulizing Crohn’s disease achieved combined fistula remission 24 weeks after initiating treatment with the IL-23 inhibitor guselkumab.
Approximately 15 percent of women with abnormal screening mammography results and adverse social determinants of health (SDOH) had follow-up diagnostic mammography or breast ultrasound within 30 days, according to multinational research presented at the Society of Breast Imaging symposium.
In a new podcast episode, interventional radiologist Suresh Vedantham, MD, FSIR, discussed the use of iliac vein stent placement for addressing the severity of post-thrombotic syndrome (PTS) and new multicenter study findings presented at the Society for Interventional Radiology (SIR) 2026 Annual Scientific Meeting.
The compact NeedleVue Mini, which reportedly offers advanced guidance for existing ultrasound systems, will be among the NeedleVue platforms showcased at the Society of Interventional Radiology (SIR) Annual Meeting in Toronto.
Providing automated tracking and image guidance of the Edwards PASCAL Ace mitral valve repair device, the DeviceGuide reportedly enables integration of live ultrasound and X-ray images into a single view.
In a new podcast episode, Daniel George, M.D., Brian Helfand, M.D., Ph.D., and Ashesh Jani, M.D., discussed recent study findings presented at the ASCO-GU symposium, directions for future research and emerging trends in molecular imaging that may help advance precision medicine for patients with prostate cancer.
Initial breast cancer risk scoring with adjunctive AI assessment of screening mammograms increased by approximately 80 percent in a subsequent screening round for women with breast cancer, according to research findings presented at the European Congress of Radiology.
While large language models (LLMs) may offer the promise of workflow efficiencies and streamlined documentation in radiology, LLMs may also increase exposure to cybersecurity risks, according to a presentation at the European Congress of Radiology (ECR).
Combining an 85 cm bore, high resolution and accelerated image reconstruction, the Rembra CT platform can reportedly handle up to 270 CT exams a day.
In a recent interview, Ashesh Jani, M.D., discussed pertinent findings in two post-hoc studies from the SPOTLIGHT trial that examined the efficacy of 18F-flotufolastat PET/CT for detecting biochemical recurrence and bone metastases in patients with prostate cancer.
In a recent interview, Brian Helfand, M.D., Ph.D., discussed key findings from a multicenter prospective trial, presented at the ASCO-GU symposium, that compared the PET radiotracers 18F-flotufolastat and 18F piflufolastat for urinary radioactivity and detection of PCa recurrence.
In a recent interview from the ASCO-GU conference. Daniel George, M.D., discussed new study findings with 177Lu-PSMA-617 for the treatment of older taxane-naïve patients with metastatic castration-resistant prostate cancer (mCRPC) and potential implications for future research.
In comparison to 68Ga-PSMA-11, 64Cu-SAR-bisPSMA more than doubled the rate of detection for prostate cancer recurrence and facilitated changes to the treatment plan in 44 percent of patients, according to research to be presented at the upcoming European Association of Urology (EAU) Congress.
In a recent interview from the International Stroke Conference, Jeremy Heit, M.D., Ph.D., discussed new research suggesting that AI may offer better assessment than neuroradiologists of aneurysm growth on computed tomography or magnetic resonance angiography scans.
In an interview at the recent RSNA conference, Chris Davis, DMSc, PA-C, RT, discussed key considerations with the integration of advanced practice providers (APPs) into radiology.
Catch up on the latest CT, MRI, ultrasound and PET imaging research from the recent RSNA conference.
In a reeent interview, Jenifer Pitman, M.D., discussed key findings from a large knee MRI study, presented at the RSNA conference, which demonstrated significant gender differences with ACL, MCL and medial meniscal injuries.
In a comparative study presented at the recent RSNA conference, researchers found that the combination of capsular contact length from MRI and SUVmax data from PSMA PET/CT yielded greater than 80 percent sensitivity and specificity for extraprostatic extension.
In an interview at the recent RSNA conference, Sriyesh Krishnan, M.D., discussed pertinent principles in assessing AI models, ongoing monitoring of the adjunctive value and an unyielding focus on patient care.
In a recent interview at the RSNA conference, neuroradiologist Emanuel Kanal, M.D., discussed key findings from a committee of the American Board of Magnetic Resonance Safety with respect to MRI technologist responsibilities and how the advent of remote MRI scanning and related protocols may lead to increased MRI safety.
Catch up on the latest research and insights from Constance Lehman, M.D., Rajesh Bhayana, M.D., Stamatia Destounis, M.D., and more with Diagnostic Imaging interviews from the recent RSNA conference.
In a recent interview, Tyler Coombes, M.D., and Parth Patel, M.D., discussed recent research, presented at the RSNA conference, which suggested that quantitative evaluation of non-calcified plaque volume (NCPV) may offer significant utility for cardiovascular risk stratification.
Whether it was a new advance in 3T MRI, emerging mammography-based AI technology, promising enterprise imaging platforms or new ultrasound devices, here is a recap of some of the product innovations launched or showcased at the annual RSNA conference.
Noting limitations of prostate MRI and advantages of PSMA PET/CT for detecting extraprostatic extension and lymph node involvement, researchers explored the potential utility of standalone PSMA PET/CT in prostate cancer staging in a review presented for the RSNA conference.
Reviewing an array of study presentations from the recent RSNA meeting, this author discusses insights from emerging research, ranging from the use of large language models (LLMs) in radiology reports to the potential impact of LLM assistance in differential diagnosis for brain MRIs.
In a recent interview at the RSNA conference, Rajesh Bhayana, M.D., discussed current research findings on the use of large language models (LLMs) in radiology and emerging LLMs that may have an impact.
In a recent interview at the RSNA conference, Roland Rott shared his perspective on the planned acquisition of Intelerad by GE HealthCare along with insights on key synergies and future directions.
